An outline of the methods constituting the QTAP workflow specific to each laboratory for the absolute quantification of Na/K-ATPase, P-gp, and BCRP
Criteria | The University of Manchester | Bertin Pharma |
---|---|---|
Peptide selection | In silico: CONSeQuence programa | In silico: Tohoku University algorithmb |
Standard generation | Quantitative concatenation (QconCAT) | Absolute quantification (AQUA) |
Selected peptides | Na/K-ATPase: IVEIPFNSTN[K13C]P-gp: AGAVAEEVLAAI[R13C]BCRP: VIQELGLD[K13C] | Na/K-ATPase: AAVPDA[V13C,15N]GKP-gp: FYDPL[A13C,15N]GKBCRP: SSL[L13C,15N]DVLAAR |
Digestion | Deoxycholate denaturation, Lys-C plus trypsin-based digestion | MS2Plex-based process including trypsin-based digestion |
LC-MS/MS | Nanoflow LC: nanoAcquity (Waters) with TSQ Vantage (Thermo Fisher), MRM | Normal flow LC: Flexar LC (PerkinElmer) with API5500 (AB SCIEX) MRM |